Blog

A recent comment written by Oksana Zirka Pyzik (UCL Fight the Fakes academic chapter founder and lead) published by nature reviews highlights how poor-quality or fraudulent medicines are causing extensive humanitarian and economic harm, particularly in Africa. Authors claim these products are a global problem that requires a coordinated cross-border response, including enhanced regulatory capacities and surveillance, reporting and education. Read the full comment here.

Image by the Medicine Maker Shabbir Imber Safdar, Partnership for Safe Medicines Executive Director and Fight the Fakes board member, was recently featured in the Medicine Maker online magazine. In his article “Drug Supply Chain Security Act” Shabbir discussed how the US drug supply chain is not immune to falsified medicines and what can be done to tackle the issue. The article includes enlightening examples of how these dangerous products are damaging to public health. Furthermore, Read more…

How misinformation has fuelled the sale of COVID-19 substandard and falsified medical products. A UCL Fight The Fakes lead study written by Oksana Pyzik, Dr. John Hertig, Hoda Kanso, Anika Chamba and Sofia Khan shows there is a strong link between fake news and fake medicines. As waves of COVID-19 continue to threaten public health, an increasing volume of disease-related information is widely accessible, and not all of it is accurate or reliable. The patient safety consequences remain the Read more…

Deloitte‘s report calls for international healthcare organizations to promote global standards such as, Fight the Fakes member, GS1 DataMatrix barcode for product identification across the medical supply chain in order to ensure citizens around the world have a speedy, equal, and secure access to COVID-19 vaccines. The report, which follows another publication from Deloitte on the same topic released in January 2021, recommends, among other measures, the adoption of a harmonized global standard for identification and traceability. It also Read more…